Thrombolytic Therapy Options in Stroke

Sadovsky, Richard
January 2000
American Family Physician;01/15/2000, Vol. 61 Issue 2, p485
Academic Journal
Focuses on a study by T.M. Osborn and colleagues which reviewed the use of thrombolytic therapy in patients with ischemic stroke. Specific parameters from the clinical trials; Major thrombolytic agents used in the treatment of ischemic stroke; Major factors in the study outcome.


Related Articles

  • Thrombolysis for acute stroke in Australia. Smith, Brendon J.; Simpson, Marion A.; Dewey, Helen M.; Parsons, Mark W. // Medical Journal of Australia;2/21/2011, Vol. 194 Issue 4, p212 

    A letter to the editor is presented in response to an article about the use of thrombolysis to treat acute stroke in Australia by B. P. Waxman.

  • Review: Thrombolysis increases short-term death and intracranial hemorrhage but decreases long-term death or dependence. Donnan, Geoffrey A. // ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p50 

    Presents information on a study which tested the safety and effectiveness of thrombolytic therapy for reducing mortality, intracranial hemorrhage, the improvement of functional outcome in patients with acute ischemic stroke. Methodology of the study; Results; Comments on the study.

  • Estimating the Number of Stroke Patients Eligible for Thrombolytic Treatment if Delay Could Be Avoided. Boode, Bep; Welzen, Vivian; Franke, Cees; van Oostenbrugge, Robert // Cerebrovascular Diseases;2007, Vol. 23 Issue 4, p294 

    Background: Although no data are available on the potential number of patients treatable with recombinant tissue plasminogen activator, it is said that up to 20% of all stroke patients should receive this treatment. The actual percentage treated is much lower, mainly due to delays between onset...

  • HMRI stroke group cites benefits.  // Cardiovascular Devices & Drugs;Dec2008, Vol. 14 Issue 12, p20 

    The article reports on the development by the Hunter Medical Research Institute (HMRI) Stroke Research Group of a system to fast-track stroke treatment, which could benefit thousands of Australian stroke patients. The Pre-hospital Acute Stroke Triage system or PAST Protocol reduces pre-hospital...

  • Acute stroke treatment: the end of the first decade. Buchan, Alastair M. // Practical Neurology (BMJ Publishing Group);Dec2006, Vol. 6 Issue 6, p338 

    The article discusses the developments in acute stroke treatment. The year 2006 is the end of the first decade of delivering intravenous thrombolysis for acute ischemic stroke and it has proven to be a beneficial therapeutic strategy. Meanwhile, other anti-thrombotic therapies, such as heparin...

  • Akut Ä°skemik Ä°nmede Ä°ntravenöz Trombolitik Tedavi. Bek, Semai; Kaşıkçı, Tayfun; Genç, Gençer; Akgün, Hakan; Demirkaya, Şeref; Odabaşı, Zeki // Turkish Journal of Neurology / Turk Noroloji Dergisi;Dec2009, Vol. 15 Issue 4, p174 

    Objective: The aim of this study was to review the efficacy, adverse effects and contraindications of intravenous thrombolytic treatment in acute ischemic stroke and to determine the predictive value of stroke scales applied in the first 24 hours to the three months outcome. Materials and...

  • PAW16 Actual workload of acute stroke thrombolysis: how many patients need to be assessed for each one treated? S J Slaght // Journal of Neurology, Neurosurgery & Psychiatry;Nov2010, Vol. 81 Issue 11, pe28 

    INTRODUCTION: Thrombolysis is an established acute stroke treatment. However, many hospitals are still setting up thrombolysis services, often delayed by fears over workload. While many data exist on the proportion of stroke patients receiving thrombolysis, there are few data on how many require...

  • Acute ischemic stroke treatment: State of the art. Patel, Rajan A. G.; White, Christopher J. // Vascular Medicine;02/01/2011, Vol. 16 Issue 1, p19 

    Stroke is among the leading causes of death and serious disability in the United States. Treatment of the acute ischemic stroke patient requires a multidisciplinary approach involving first-responders, emergency department personnel, neurologists, advanced imaging experts and endovascular...

  • Treatment of Acute Ischemic Stroke: Selecting the Right Treatment for the Right Patient. Adams, Jr., Harold P. // European Neurology;2001, Vol. 45 Issue 2, p61 

    At present, thrombolytic therapy is the only therapy approved for the treatment of acute brain injury among patients with ischemic stroke. While recombinant tissue plasminogen activator (rt-PA) is efficacious, its usefulness is limited, largely because of the very limited time window for its...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics